LRRK2 and Parkinson disease: Nonmanifesting LRRK2 G2019S mutation carriers also have decreased posterior putamen‐cortical FC,11, 12 and have reduced dopamine uptake in the striatum,13, 14 The dysfunction of basal ganglia motor circuit provides explains why LRRK2 G2019S mutation carriers are at high risk for developing PD.